Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P110023/S070

EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)

Medtronic Vascular, Inc. · Decision date Nov 5, 2026

MEDTECHLEDGER EXPLANATIONP110023/S070

What did the FDA decide?

FDA records this as supplement P110023/S070 for the EverFlex Self-Expanding Peripheral Stent System, under the PMA identifier P110023. The entry is a 30-Day Notice supplement, so it is a change to the cleared PMA record rather than a new approval of the full device system.

The stated action is limited to “manufacturing and process validation changes” for “the delivery systems” of the EverFlex and Protege GPS Self-Expanding Peripheral Stent Systems. The record does not describe the specific process change, the revised components, or any new clinical data, so those details remain unknown from this entry alone.

FDA approval order statement

approval for manufacturing and process validation changes for the delivery systems of the EverFlex and Protege GPS Self-Expanding Peripheral Stent Systems
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Nov 5, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P110023/S070
Regulatory pathway
PMA supplement
Product code
NIP
Decision code
OK30
Decision date
Nov 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.

Product code
NIP
FDA device class
3

For the original device and its historical approval scope, see PMA P110023. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P110023 · Original PMA

    EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)

  2. P110023/S070 received

    Application receipt date recorded by FDA.

  3. P110023/S069 · Related supplement

    EverFlex Self-Expanding Peripheral Stent System; EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste

  4. P110023/S070 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P110023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P110023

Explore the linked device profile

Other records with product code NIP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records